NASDAQ: QUREUniqure Nv Stock Ownership - Who owns Uniqure Nv?
Insider buying vs selling
Have Uniqure Nv insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Robert Gut | Director | 2026-01-12 | 17,810 | $14.08 | $250.76kBuy |
| Robert Gut | Director | 2026-01-12 | 7,803 | $25.09 | $195.78kSell |
| Robert Gut | Director | 2026-01-12 | 500 | $25.03 | $12.52kSell |
| Robert Gut | Director | 2026-01-12 | 17,310 | $24.39 | $422.19kSell |
| Jack Kaye | Director | 2026-01-09 | 6,390 | $27.28 | $174.32kSell |
| Jack Kaye | Director | 2026-01-09 | 6,390 | $19.39 | $123.90kBuy |
| Robert Gut | Director | 2025-11-06 | 15,840 | $27.22 | $431.16kSell |
| Robert Gut | Director | 2025-11-06 | 15,840 | $4.57 | $72.39kBuy |
| Robert Gut | Director | 2025-11-06 | 15,594 | $27.30 | $425.72kSell |
| Jack Kaye | Director | 2025-11-04 | 17,810 | $14.08 | $250.76kBuy |
QURE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when QURE insiders and whales buy or sell their stock.
QURE Shareholders
What type of owners hold Uniqure Nv stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Fmr LLC | 10.02% | 6,240,936 | $146.23M | Institution |
| Avoro Capital Advisors LLC | 9.87% | 6,150,000 | $144.09M | Institution |
| Bv Foruniqure | 7.03% | 4,376,883 | $102.55M | Insider |
| Rtw Investments LP | 5.96% | 3,711,462 | $86.96M | Institution |
| Aberdeen Group PLC | 5.91% | 3,678,640 | $86.19M | Institution |
| State Street Corp | 5.19% | 3,231,043 | $75.70M | Institution |
| Jpmorgan Chase Co | 4.71% | 2,934,626 | $68.76M | Institution |
| Blackrock Inc | 3.17% | 1,974,988 | $46.27M | Institution |
| Two Sigma Investments LP | 2.33% | 1,451,284 | $34.00M | Institution |
| Mpm Bioimpact LLC | 2.22% | 1,381,628 | $32.37M | Institution |
QURE vs Biotech Stocks
Uniqure Nv Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.